Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Latest News

Market capAny size
All Over $50MOver $300MOver $2BOver $10B
All Under $1BUnder $10BUnder $100BUnder $500B
SectorsAll
Filter by sector
Thursday, October 15, 2026· 10183 stock ideas· 217 writers·
15,261 views· 7,255 clicks

Constellation: Stars Aligning?

Constellation Brands trades near $127 at roughly 11x next-twelve-month EV/EBIT, with recent business results offsetting concerns over cannabis, craft beer and dealmaking.

STZ $21B
TSOH Investment Research 8 clicks

From X

@convequity

Convequity on X

$TSEM remains one of our highest-conviction holdings, even after we trimmed the position in our 4Q26 rebalance. We wanted to keep Tower at its 6.1% portfolio weight despite a roughly 25% fall in its share price over the past quarter. To make room for new holdings, we trimmed the weight to 4.75% and banked some profits. With SpaceX ($SPCX) also becoming a larger holding, we are limiting further additions to avoid concentrating the portfolio in a few companies. Our confidence in Tower's technology remains strong. We think Tower's competitive advantage comes from combining chips that send and receive data using light with the electronic chips that drive and control them. Next-generation optical connections require these components to exchange more data within a smaller space. Hybrid bonding achieves this by joining the chips through densely packed electrical connections that move large amounts of data in a compact package. In our view, Tower's capabilities here are effectively unmatched among Western suppliers. Tower has also added manufacturing capacity more successfully than we expected. It can fulfill more customer orders itself, leaving less business for $GFS. Customers have less reason to switch to a supplier whose technology they consider weaker when Tower can meet their needs, so the capacity expansion strengthens our Tower thesis and weakens the case for competitors that rely on orders Tower cannot accommodate.
@StableBread

Fajasy on X

The CEO of Nubeva Technologies $NBVAF (TSXV: $NBVA) expects its third AI patent to be approved within two months, calling the rest “signature paperwork.” Nubeva, a ransomware recovery company, has been granted two of the four AI patents it applied for in 2024. CEO Randy Chou said in his October 5, 2026 interview on Nubeva’s YouTube channel that the patent office had sent an amendment on the third patent that week, which Nubeva plans to accept. The third patent covers detecting “nefarious or improper encryption” inside a binary (a compiled program in machine code), meaning Nubeva can tell when malware is encrypting files, even when the encryption is hidden. Spotting hidden encryption is also what drew AI data labeling companies (firms that turn experts’ knowledge into training data for AI labs) to Nubeva, Chou said. Nubeva hasn’t heard back on the fourth patent. Chou said the patent office told the company that AI patent applications are now taking much longer, with examiners reading filings as long as 150 pages vs. the ~30 pages he typically files (probably because of AI writing the patents). So the fourth patent, the last one Chou wants granted before pursuing a potential partnership or sale, is just a waiting game.

Investor Letters

All letters

Free Recaps of the best new stock ideas, delivered every morning.

Read past recaps

My 2028 numbers

ASML’s €11.7 billion quarter benefited from €3.3 billion in installed-base sales and operating leverage, while the MATCH Act threatens…

ASML $660B
Best Anchor Stocks 21 clicks

Lennar, Part One: The Story

Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…

LEN $17B
Latticework by MOI Global 8 clicks

Lennar, Part Two: The Deep Dive

Lennar’s second audio program examines the homebuilder’s business for professional investors and housing analysts.

LEN $17B
Latticework by MOI Global 11 clicks

ASML Q3 FY12/26 Earnings Review

ASML reported Q3 sales of €11.7 billion, up 55% year over year, and guided Q4 sales to €14.2 billion to €15.2 billion amid capacity…

ASML $660B
Cestrian Capital Research 7 clicks

Insider activity September 2026

Asian insider buying rose 19% to US$2.4 billion across 930 September transactions, led by Grab CEO Anthony Tan’s US$30 million purchase…

GRAB $12B
Asian Century Stocks 6 clicks
SRTA · long

Strata Critical Medical INC

Strata Critical Medical, SRTA, supplies organ-transport products tied to U.S. transplant growth.

SRTA $404M
Value Investors Club 3 clicks

Have a source we’re missing? Send your pick

Recent recaps

Latest recap

Wednesday, October 14 70 stock ideas
  • October 2026 Random Ramblings Yet Another Value Podcast
  • Visa: Unpacking The 7 Powers And Forward Valuation Ahead Of Q4 Earnings Seeking Alpha
Read the recap

All recaps

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 49 of 225

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

88 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.

Anything we’re missing?

Send us a pick